News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years
As shedding slows, restoring volume becomes the next priority
By reducing oxidative stress, these antioxidants indirectly support the preservation of glutathione levels
Systemic Inflammation Reduction BPC-157 modulates several inflammatory cytokines and activates anti-inflammatory signaling pathways
For people who are overweight or living with obesity and an autoimmune disease, this study offers a hopeful signal that medications already in use today may be beneficial in reducing their risk of cardiovascular disease.More informationThe Mayo Clinic has more on GLP-1 drug benefits.SOURCE: American Heart Association, news release, June 6, 2026 .What This Means For YouPeople with autoimmune diseases and obesity should ask their doctor about GLP-1 drugs..Sign up for our weekly HealthDay newsletter